_id
690db205ccc777a4e85d0c38
Ticker
ASTC
Name
Astrotech Corp
Exchange
NASDAQ
Address
2105 Donley Drive, Austin, TX, United States, 78758
Country
USA
Sector
Technology
Industry
Scientific & Technical Instruments
Currency
USD
Website
https://www.astrotechcorp.com
Description
Astrotech Corporation operates as a mass spectrometry company worldwide. It owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology, a platform mass spectrometry technology. The company also develops TRACER 1000, a mass spectrometer-based explosive trace detector to replace the explosives trace detectors used at airports, border checkpoints, cargo hubs, infrastructure security, correctional facilities, military bases, and law enforcement centers. In addition, it develops AGLAB-1000, a mass spectrometer for use in the hemp and cannabis market. Further, the company develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath; and Pro-Control 1000-D2, a mass spectrometer; and EN-SCAN to detect soil, water, and air contamination source location and migration. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. The company was incorporated in 1984 and is based in Austin, Texas.
Last Close
4.0822
Volume
11810
Current Price
4.2
Change
2.885698887854586
Last Updated
2025-11-28T12:28:09.394Z
Image
data:image/webp;base64,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
Ipo Date
1995-12-20T00:00:00.000Z
Market Cap
5716600
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.8634999999999999
Sentiment Sources
2
Current Quarter
2025-09-30
Revenue
297000
Cost Of Revenue
109000
Gross Profit
188000
Operating Expenses
3724000
Operating Income
-3536000
Interest Expense
-
Pretax Income
-3465000
Net Income
-3465000
Eps
-2.071129707112971
Dividends Per Share
-
Shares Outstanding
1758953
Income Tax Expense
-
EBITDA
-3163000
Operating Margin
-1190.5723905723908
Total Other Income Expense Net
71000
Cash
2646000
Short Term Investments
11290000
Receivables
354000
Inventories
3082000
Total Current Assets
18193000
Property Plant Equipment
4650000
Total Assets
23240000
Payables
613000
Short Term Debt
384000
Long Term Debt
-
Total Liabilities
4152999
Equity
19087000
Depreciation
302000
Change In Working Capital
-1078000
Cash From Operations
-3936000
Capital Expenditures
448000
Cash From Investing
3518000
Cash From Financing
-36000
Net Change In Cash
-454000
PE
-
PB
0.3681353801016399
ROE
-18.153717189710274
ROA
-14.909638554216867
FCF
-4384000
Fcf Percent
-14.760942760942761
Piotroski FScore
0
Health Score
33
Deep Value Investing Score
6.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
4.5
Growth Investing Score
3
Momentum Investing Score
4.5
Net Net Investing Score
7
Quality Investing Score
3
Value Investing Score
5.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
297000
Quarters > 0 > income Statement > cost Of Revenue
109000
Quarters > 0 > income Statement > gross Profit
188000
Quarters > 0 > income Statement > operating Expenses
3724000
Quarters > 0 > income Statement > operating Income
-3536000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-3465000
Quarters > 0 > income Statement > net Income
-3465000
Quarters > 0 > income Statement > eps
-2.071129707112971
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1673000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-3163000
Quarters > 0 > income Statement > operating Margin
-1190.5723905723908
Quarters > 0 > income Statement > total Other Income Expense Net
71000
Quarters > 0 > balance Sheet > cash
2646000
Quarters > 0 > balance Sheet > short Term Investments
11290000
Quarters > 0 > balance Sheet > receivables
354000
Quarters > 0 > balance Sheet > inventories
3082000
Quarters > 0 > balance Sheet > total Current Assets
18193000
Quarters > 0 > balance Sheet > property Plant Equipment
4650000
Quarters > 0 > balance Sheet > total Assets
23240000
Quarters > 0 > balance Sheet > payables
613000
Quarters > 0 > balance Sheet > short Term Debt
384000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
4152999
Quarters > 0 > balance Sheet > equity
19087000
Quarters > 0 > cash Flow > net Income
-3465000
Quarters > 0 > cash Flow > depreciation
302000
Quarters > 0 > cash Flow > change In Working Capital
-1078000
Quarters > 0 > cash Flow > cash From Operations
-3936000
Quarters > 0 > cash Flow > capital Expenditures
448000
Quarters > 0 > cash Flow > cash From Investing
3518000
Quarters > 0 > cash Flow > cash From Financing
-36000
Quarters > 0 > cash Flow > net Change In Cash
-454000
Quarters > 0 > ratios > PE
-2.071129707112971
Quarters > 0 > ratios > PB
0.3681353801016399
Quarters > 0 > ratios > ROE
-18.153717189710274
Quarters > 0 > ratios > ROA
-14.909638554216867
Quarters > 0 > ratios > FCF
-4384000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-14.760942760942761
Quarters > 0 > health Score
33
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
220000
Quarters > 1 > income Statement > cost Of Revenue
477000
Quarters > 1 > income Statement > gross Profit
-257000
Quarters > 1 > income Statement > operating Expenses
2661000
Quarters > 1 > income Statement > operating Income
-2918000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-2928000
Quarters > 1 > income Statement > net Income
-2930000
Quarters > 1 > income Statement > eps
-1.7597597597597598
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1665000
Quarters > 1 > income Statement > income Tax Expense
2000
Quarters > 1 > income Statement > EBITDA
-2597000
Quarters > 1 > income Statement > operating Margin
-1326.3636363636363
Quarters > 1 > income Statement > total Other Income Expense Net
-10000
Quarters > 1 > balance Sheet > cash
3100000
Quarters > 1 > balance Sheet > short Term Investments
15108000
Quarters > 1 > balance Sheet > receivables
485000
Quarters > 1 > balance Sheet > inventories
2929000
Quarters > 1 > balance Sheet > total Current Assets
21975000
Quarters > 1 > balance Sheet > property Plant Equipment
4620000
Quarters > 1 > balance Sheet > total Assets
26989000
Quarters > 1 > balance Sheet > payables
1066000
Quarters > 1 > balance Sheet > short Term Debt
405000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
4889000
Quarters > 1 > balance Sheet > equity
22100000
Quarters > 1 > cash Flow > net Income
-2930000
Quarters > 1 > cash Flow > depreciation
331000
Quarters > 1 > cash Flow > change In Working Capital
-161000
Quarters > 1 > cash Flow > cash From Operations
-2361000
Quarters > 1 > cash Flow > capital Expenditures
348000
Quarters > 1 > cash Flow > cash From Investing
2677000
Quarters > 1 > cash Flow > cash From Financing
-28000
Quarters > 1 > cash Flow > net Change In Cash
288000
Quarters > 1 > ratios > PE
-1.7597597597597598
Quarters > 1 > ratios > PB
0.31642533936651585
Quarters > 1 > ratios > ROE
-13.2579185520362
Quarters > 1 > ratios > ROA
-10.856274778613509
Quarters > 1 > ratios > FCF
-2709000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-12.313636363636364
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
534000
Quarters > 2 > income Statement > cost Of Revenue
297000
Quarters > 2 > income Statement > gross Profit
237000
Quarters > 2 > income Statement > operating Expenses
4104000
Quarters > 2 > income Statement > operating Income
-3867000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-3633000
Quarters > 2 > income Statement > net Income
-3633000
Quarters > 2 > income Statement > eps
-2.181981981981982
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1665000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-3350000
Quarters > 2 > income Statement > operating Margin
-724.1573033707865
Quarters > 2 > income Statement > total Other Income Expense Net
234000
Quarters > 2 > balance Sheet > cash
2812000
Quarters > 2 > balance Sheet > short Term Investments
18057000
Quarters > 2 > balance Sheet > receivables
523000
Quarters > 2 > balance Sheet > inventories
2752000
Quarters > 2 > balance Sheet > total Current Assets
24575000
Quarters > 2 > balance Sheet > property Plant Equipment
2521000
Quarters > 2 > balance Sheet > total Assets
27492000
Quarters > 2 > balance Sheet > payables
616000
Quarters > 2 > balance Sheet > short Term Debt
66000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2740000
Quarters > 2 > balance Sheet > equity
24752000
Quarters > 2 > cash Flow > net Income
-3633000
Quarters > 2 > cash Flow > depreciation
283000
Quarters > 2 > cash Flow > change In Working Capital
-664000
Quarters > 2 > cash Flow > cash From Operations
-3861000
Quarters > 2 > cash Flow > capital Expenditures
27000
Quarters > 2 > cash Flow > cash From Investing
3590000
Quarters > 2 > cash Flow > cash From Financing
-78000
Quarters > 2 > cash Flow > net Change In Cash
-349000
Quarters > 2 > ratios > PE
-2.181981981981982
Quarters > 2 > ratios > PB
0.28252262443438914
Quarters > 2 > ratios > ROE
-14.677601809954751
Quarters > 2 > ratios > ROA
-13.214753382802268
Quarters > 2 > ratios > FCF
-3888000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-7.280898876404494
Quarters > 2 > health Score
33
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
261000
Quarters > 3 > income Statement > cost Of Revenue
106000
Quarters > 3 > income Statement > gross Profit
155000
Quarters > 3 > income Statement > operating Expenses
4476000
Quarters > 3 > income Statement > operating Income
-4321000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-4009000
Quarters > 3 > income Statement > net Income
-4009000
Quarters > 3 > income Statement > eps
-2.4474969474969477
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1638000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-4047000
Quarters > 3 > income Statement > operating Margin
-1655.5555555555557
Quarters > 3 > income Statement > total Other Income Expense Net
312000
Quarters > 3 > balance Sheet > cash
3161000
Quarters > 3 > balance Sheet > short Term Investments
21531000
Quarters > 3 > balance Sheet > receivables
344000
Quarters > 3 > balance Sheet > inventories
2649000
Quarters > 3 > balance Sheet > total Current Assets
28163000
Quarters > 3 > balance Sheet > property Plant Equipment
2808000
Quarters > 3 > balance Sheet > total Assets
31001000
Quarters > 3 > balance Sheet > payables
1032000
Quarters > 3 > balance Sheet > short Term Debt
81000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2907000
Quarters > 3 > balance Sheet > equity
28094000
Quarters > 3 > cash Flow > net Income
-4009000
Quarters > 3 > cash Flow > depreciation
274000
Quarters > 3 > cash Flow > change In Working Capital
353000
Quarters > 3 > cash Flow > cash From Operations
-3044000
Quarters > 3 > cash Flow > capital Expenditures
319000
Quarters > 3 > cash Flow > cash From Investing
-279000
Quarters > 3 > cash Flow > cash From Financing
-34000
Quarters > 3 > cash Flow > net Change In Cash
-3357000
Quarters > 3 > ratios > PE
-2.4474969474969477
Quarters > 3 > ratios > PB
0.24487790987399446
Quarters > 3 > ratios > ROE
-14.269950879191287
Quarters > 3 > ratios > ROA
-12.931840908357795
Quarters > 3 > ratios > FCF
-3363000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-12.885057471264368
Quarters > 3 > health Score
34
Valuation > metrics > PE
-2.071129707112971
Valuation > metrics > PB
0.3681353801016399
Valuation > final Score
70
Valuation > verdict
63.2% Undervalued
Profitability > metrics > ROE
-18.153717189710274
Profitability > metrics > ROA
-19.045786841092728
Profitability > metrics > Net Margin
-11.666666666666666
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.21758259548383715
Risk > metrics > Interest Coverage
-11.708609271523178
Risk > final Score
13
Risk > verdict
High
Liquidity > metrics > Current Ratio
18.247743229689068
Liquidity > metrics > Quick Ratio
15.156469408224673
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
25
Prev Risks > 1
5
Prev Risks > 2
-395
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:14:49.430Z
Astrotech Corporation operates as a mass spectrometry company worldwide. It owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology, a platform mass spectrometry technology. The company also develops TRACER 1000, a mass spectrometer-based explosive trace detector to replace the explosives trace detectors used at airports, border checkpoints, cargo hubs, infrastructure security, correctional facilities, military bases, and law enforcement centers. In addition, it develops AGLAB-1000, a mass spectrometer for use in the hemp and cannabis market. Further, the company develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath; and Pro-Control 1000-D2, a mass spectrometer; and EN-SCAN to detect soil, water, and air contamination source location and migration. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. The company was incorporated in 1984 and is based in Austin, Texas.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AStock Report: Can NGL Energy Partners LP stock continue upward trend - Earnings Beat & Long-Term Growth Plans moha.gov.vn
Read more →Sell Signal: How STUB stock performs during market turbulence - Rate Hike & Precise Swing Trade Alerts moha.gov.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 20.19% of the total shares of Astrotech Corp
1.
BML Capital Management LLC(13.0116%)
since
2025/06/30
2.
Vanguard Group Inc(3.1674%)
since
2025/06/30
3.
BlackRock Inc(1.1918%)
since
2025/06/30
4.
Geode Capital Management, LLC(1.1086%)
since
2025/06/30
5.
Dimensional Fund Advisors, Inc.(0.8122%)
since
2025/06/30
6.
Scs Capital Management LLC(0.6943%)
since
2025/06/30
7.
UBS Group AG(0.1776%)
since
2025/06/30
8.
Tower Research Capital LLC(0.0148%)
since
2025/06/30
9.
Bank of America Corp(0.0068%)
since
2025/06/30
10.
HARBOUR INVESTMENTS, INC.(0.0019%)
since
2025/06/30
11.
Federation des caisses Desjardins du Quebec(0.0014%)
since
2025/06/30
12.
Wells Fargo & Co(0.0008%)
since
2025/06/30
13.
SBI Securities Co Ltd(0.0002%)
since
2025/06/30
14.
Susquehanna International Group, LLP(0%)
since
2025/06/30
15.
Td Capital Management LLC(0%)
since
2025/03/31
16.
Citadel Advisors Llc(0%)
since
2025/06/30
17.
JPMorgan Chase & Co(0%)
since
2025/06/30
18.
Advisor Group Holdings, Inc.(0%)
since
2025/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.